A Study to Evaluate ALN-BCAT in Patients With Hepatocellular Carcinoma
Clinical trial NCT06600321 · RECRUITING
Trial details
- NCT number
- NCT06600321
- Sponsor
- Alnylam Pharmaceuticals
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-12-30
- Primary completion
- 2027-09-30
- Enrollment
- 158
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.